GlassScriptPhysician profile
Todd Wedel
NPI 1174108534
$444.23
in general payments reported to CMS, 2019-2025
9 companies · $84.01 in 2025
The $84.01 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.66 · 2022: $286 · 2023: $40.24 · 2024: $21.40 · 2025: $84.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $145.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $147.19 | 2021-2024 | Myday Contact Lens, Clariti Contact Lens |
| Johnson & Johnson Vision Care, INC. | $60.60 | 2022 | |
| Bausch & Lomb Americas INC. | $59.74 | 2025 | Xiidra, Miebo, Infuse |
| Abbvie INC. | $46.68 | 2022 | |
| Alcon Vision LLC | $37.21 | 2022-2023 | Total30 |
| Biotissue Holdings INC. | $24.58 | 2022 | |
| Rxsight INC | $24.27 | 2025 | Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens, Rxsight Injector Handpiece |
| Novartis Pharmaceuticals Corporation | $22.91 | 2022 | |
| Thea Pharma INC. | $21.05 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Wedel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.